Medical devices, healthcare technology and the business of care
510(k) clearance · K262621

Rapid Barostat Bag (RBB) Pump and Catheter System

Mui Scientific, Inc. · Decision date Sep 30, 2026

MEDTECHLEDGER EXPLANATIONK262621

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 30, 2026 for the Rapid Barostat Bag (RBB) Pump and Catheter System, submitted by Mui Scientific, Inc. of Mississauga, Ontario, under 510(k) number K262621. The device falls under regulation 876.1725 with product code FFX, in the Gastroenterology/Urology specialty, and the application was received July 28, 2026. A SESE decision is a 510(k) clearance, not a PMA approval.

The review letter describes the submission as covering changes that included replacing certain components and suppliers with equivalent alternatives to reduce risk and improve efficiency, along with minor design changes. The available excerpts do not identify which components or suppliers were replaced, the specific design changes, or the predicate device relied upon; the summary document itself was not reviewed here. No clinical performance, efficacy or patient-selection information is established by this record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Gastroenterology, Urology
Decision date
Sep 30, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262621
Regulatory pathway
510(k) premarket notification
Product code
FFX
Decision code
SESE
Decision date
Sep 30, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, Gastrointestinal Motility (Electrical).

Product code
FFX
FDA device class
2

FDA decision timeline

  1. K262621 received

    Application receipt date recorded by FDA.

  2. K262621 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Mui Scientific, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Mississauga

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records